TRVI
TRVI
US89532M1018
Trevi Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
49.328.000 51.524.000
4.3%
Operating Income -49.328.000 -51.524.000
4.3%
Pretax Income -42.823.000 -47.941.000
10.7%
Net Income Common Stockholders -42.759.000 -47.911.000
10.8%
-- --
--
-- --
--
ende